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Abstract
Background: Rare missense mutations in the gene encoding coatomer subunit alpha (COPA) have recently been
shown to cause autoimmune interstitial lung, joint and kidney disease, also known as COPA syndrome, under a
dominant mode of inheritance.
Case presentation: Here we describe an Icelandic family with three affected individuals over two generations with
a rare clinical presentation of lung and joint disease and a histological diagnosis of follicular bronchiolitis. We performed
whole-genome sequencing (WGS) of the three affected as well as three unaffected members of the family, and searched
for rare genotypes associated with disease using 30,067 sequenced Icelanders as a reference population. We assessed all
coding and splicing variants, prioritizing variants in genes known to cause interstitial lung disease. We detected a
heterozygous missense mutation, p.Glu241Lys, in the COPA gene, private to the affected family members. The
mutation occurred de novo in the paternal germline of the index case and was absent from 30,067 Icelandic
genomes and 141,353 individuals from the genome Aggregation Database (gnomAD). The mutation occurs
within the conserved and functionally important WD40 domain of the COPA protein.
Conclusions: This is the second report of the p.Glu241Lys mutation in COPA, indicating the recurrent nature of the
mutation. The mutation was reported to co-segregate with COPA syndrome in a large family from the USA with five
affected members, and classified as pathogenic. The two separate occurrences of the p.Glu241Lys mutation in cases and
its absence from a large number of sequenced genomes confirms its role in the pathogenesis of the COPA syndrome.
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Background
Autoimmune interstitial lung, joint, and kidney disease
(AILJK) is an immunodeficiency disorder identified in 2015
that impacts pulmonary, renal, and connective tissue func-
tion [1]. It is also termed COPA syndrome since it is caused
by heterozygous missense mutations in the COPA gene
(specifically in the WD40 domain of the coatomer subunit
alpha). COPA syndrome is inherited under autosomal
dominant mode of inheritance with variable expressivity.
Most COPA syndrome patients present early in life, with
lung biopsies showing follicular bronchiolitis. Additionally,
pulmonary hemorrhage is often a presenting feature of the
disease [1]. The COPA gene encodes the alpha subunit of
the coatomer protein complex (COPI), a carrier complex
required for retrograde protein trafficking from the Golgi
to the endoplasmic reticulum (ER) [2]. The pathological
mechanism of COPA syndrome is thought to consist of
impaired return of proteins from the Golgi to the ER. This
deficit of proteins is compensated for by increasing protein
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translation which in turn increases ER stress and results in
abnormal cellular autophagy [2].
To date, four missense mutations in COPA have been
reported in a single publication in individuals within five
families with COPA syndrome [2]. All four mutations
cluster within a 14 amino acid stretch (residues 230-243)
in the functionally important WD40 domain of the COPA
protein (Fig. 1). WD-repeat proteins are made up of highly
conserved repeating units and regulate important cellular
functions, such as cell division, cell-fate determination,
and vesicular trafficking and fusion [3–5]. The importance
of these proteins is further highlighted by the fact that
disruption of the gene that encodes the alpha-subunit
of the COPI in yeast (RET1P), a protein containing four
WD-40 repeated motifs, is lethal [6].
The development of follicular bronchiolitis is a common
feature of COPA syndrome [1]. Follicular bronchiolitis is
characterized by the presence of hyperplastic lymphoid
follicles with germinal centers in the walls of small airways
[7]. This histopathology can be seen in several clinical
settings, such as immunodeficiency, connective tissue
diseases, autoimmune diseases, and interstitial lung dis-
eases in both children and adults.
In the current study, we analyzed an Icelandic family,
with three members carrying the diagnosis of follicular
bronchiolitis (Fig. 2). Six family members (including
the three affected) were whole-genome sequenced
with the aim of searching for rare sequence variants
causing the condition.
Case presentation
The index case of the study (II-3, b. 1978) first sought
medical attention at the age of 32 because of exercise
intolerance. She had previously been diagnosed with hay
fever and juvenile arthritis and had no history of smoking.
Lung biopsy taken at the age of 33 showed chronic bron-
chiolitis, multiple foci of lymphoid hyperplasia in the
pulmonary interstitium and mild interstitial lymphoid
infiltrate. Additionally, distal acinar emphysema and
multifocal interstitial neuroendocrine cell hyperplasia
was noted. These results lead to the histological diagnosis
of follicular bronchiolitis (Additional file 1: Figure S1).
The index case (II-3) had progressive dyspnea and re-
spiratory tract infections over the next several years
and required supplemental oxygen. Pulmonary function
testing performed at age 43 showed severe restrictive
lung disease with a very low diffusing capacity for carbon
monoxide (DLCO) (Additional file 2: Table S1). She
underwent a bilateral lung transplant at the age of 44. II-3
has two affected offspring, a son born in 1988 (III-1) and a
daughter born in 1995 (III-2). III-1 was initially diagnosed
with asthma at 11 years of age. Additionally, he had diffuse
intra-alveolar hemorrhage and presented with arthritis of
wrists, fingers, ankles and knees. He had an open lung
biopsy at 13 years of age, which showed chronic bron-
chiolitis, multiple lymphoid follicles adjacent to terminal
bronchioles and in the pulmonary interstitium and small
peripheral cyst formations. This lead to the histological
diagnosis of follicular bronchiolitis (Additional file 3:
Figure S2).
Similar to his mother he experienced increasing exercise
intolerance and recurrent respiratory infections over the
Fig. 1 Illustration of the COPA protein. Previously reported mutations in COPA (Watkin et al., 2015) all cluster within a 14 amino acid stretch in the COPA
protein. The mutation detected in the Icelandic pedigree is listed in red. The current report marks the second observation of the p.Glu241Lys mutation
Fig. 2 The three-generation family. Shown are genotypes of the
COPA mutation (W: wild-type allele, M: mutated allele). Blackened
symbols denote affected individuals, unblackened symbols denote
unaffected individuals, and the slashed line denotes deceased. The
genotypes of the siblings of the index case (II-3) were obtained with
Sanger sequencing and the other six family members were
whole-genome sequenced
Jensson et al. BMC Medical Genetics  (2017) 18:129 Page 2 of 5
next several years and required supplementary oxygen.
At the age of 28, his pulmonary function had worsened
considerably and showed severe obstructive lung disease,
with hyperinflation and air-trapping along with very low
DLCO (Additional file 2: Table S1). He received a bilateral
lung transplant at 28 years of age, after we performed the
whole-genome sequencing.
III-2 was diagnosed with juvenile rheumatoid arthritis at
18 months of age. From the age of 10, she had exercise in-
tolerance, recurrent respiratory infections and a recurring
skin condition. She had a lung biopsy at 13 years of age that
showed chronic bronchiolitis as well as multiple lymphoid
follicles adjacent to bronchioles and in the interstitium,
which lead to her being histologically diagnosed with
follicular bronchiolitis (Additional file 4: Figure S3).
Additional autoimmune and rheumatological features for
all three patients can be found in Additional file 5: Table S2
as well as a summary of the treatment they received. The
CARE guidelines were followed in this case description.
In our analysis, we assessed all coding and splice variants
prioritizing variants in genes known to cause interstitial
lung disease (detailed description in Additional file 6:
Supplementary Information). Before the analysis, the most
compatible inheritance model was found to be autosomal
dominant, since three individuals of both genders in subse-
quent generations were affected with the same disease.
The parents of the index case are both Icelandic and have
currently reached 75 and 72 years of age, respectively, and
do not have a diagnosis of lung disease.
When searching for the causative genotype under an
autosomal dominant mode of inheritance in the affected
family members we filtered out mutations with MAF over
0.1% in Iceland (see Additional file 6: Supplementary Infor-
mation and Additional file 7: Figure S4). For each of the
remaining variants we checked if they were in genes known
to cause human disease [8]. Whole-genome sequencing
revealed amissensemutation (NM_001098398.1: c.721G >A
/ NP_004362.2: p.Glu241Lys) in the COPA gene, private to
the three affected family members (Additional file 8: Table
S3). The presence of the mutation in cases and its absence
from other family members (including the two parents of
the index case) was confirmed with Sanger sequencing,
indicating a de novo mutation in the index case
(Additional file 9: Table S4). Additionally, the mutation
was absent from the genomes of 30,067 Icelanders who
have been whole-genome sequenced to an average depth
of at least 30× at deCODE genetics, and from 141,353
genomes/exomes publically available on the genome
Aggregation Database (gnomAD) [9]. No other candidates,
likely to explain the disease in the affected family mem-
bers, were detected in our analysis.
The p.Glu241Lys mutation was the only coding or
splice de novo mutation in the index case. In order to
confirm that the mutation occurred de novo, we checked
and confirmed the relationship between the index case
and her two unaffected parents by haplotype sharing
between them, as well as the transmission of rare variants.
Additionally, by using haplotype sharing between the
family members we found out that the de novo mutation
was present on the paternal haplotype background of the
index case. Whole-genome and Sanger sequencing of a
blood sample from the father (I-1) both show no traces
of the mutation, consistent with the mutation occurring
de novo in the paternal germline of the index case
(Additional file 9: Table S4).
The p.Glu241Lys mutation is a known pathogenic muta-
tion, reported in five affected individuals with hereditary
autoimmune-mediated lung disease and arthritis [2] from a
family of Irish/Native American descent (Anthony Shum,
personal communication). In vitro functional expression
assays performed by Watkin et al. [2] showed that the
mutation caused impaired binding to a dilysine reporter,
suggesting that it causes a defect in retrograde transport
from the Golgi to the endoplasmic reticulum. Table 1 lists
the phenotypic overlap between these individuals and the
ones described in the present study, which includes lung
and joint disorders. No signs of kidney disease were
observed in the two families.
Discussion and conclusions
This report marks the second occurrence of the p.Glu241Lys
mutation in cases with COPA syndrome. The mutation
occurred de novo in the paternal germline of the index
case and was inherited by her two affected offspring
with lung and joint disease. The recurrence of the
mutation in Iceland raises the question whether the
genomic position (chr1:160,314,111, hg38) is highly
mutable. In addition, as initially reported, all pathogenic
COPA mutations cluster in a 14 amino acid interval of the
WD40 domain. It remains to be understood if this area has
a higher mutation rate than other regions of the gene or
alternatively is the only region with a pathogenic potential.
Recurrent de novo mutations in ATP1A3 and FGFR3 were
previously reported to cause the majority of cases in alter-
nating hemiplegia of childhood [10] and achondroplasia
[11], respectively, which similarly lead to the speculation of
a hypermutable sequence in those genes.
The p.Glu241Lys mutation was first reported in five
affected individuals with COPA syndrome from a large
family in the US (Family C) [2]. The US family included
55 individuals over six generations, where whole-exome
sequencing was performed of five affected individuals
and four unaffected members of the pedigree. All five
affected individuals carried the p.Glu241Lys mutation in
addition to two unaffected family members, indicating
incomplete penetrance, although it is possible that
clinical information on the two unaffected carriers was
missing. In the current Icelandic pedigree, the mutation is
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fully penetrant and private to the three affected family mem-
bers. Interestingly, both families carrying the p.Glu241Lys
mutation have normal kidney function in contrast to
the other four families (families A, B, D, and E) [2]. This
suggests that the mutation does not have deleterious
effects on renal function.
COPA is a highly constrained gene, with a large deficit
in both missense (273 vs. 429, z-score: 3.69) and loss of
function (0 vs. 54, pLI-score: 1.00) mutations [12, 13].
Furthermore, the mutation position (chr1:160,314,111) is
highly conserved as indicated by its GERP [14] score of 5.62
(Additional file 8: Table S3). This means that predicted loss-
of-function mutations (frameshift, stop, and essential splice)
in COPA would have the same deleteriousness as missense
mutations in the WD40 domain. This is consistent with
functional results performed by Watkin et al. [2], showing
that COPA missense mutations result in a defective COPA
protein, although it remains uncertain whether the mu-
tations produce disease through a dominant-negative or
haploinsufficient effect [1].
To our knowledge, this is the second report of a
pathogenic mutation in COPA. The p.Glu241Lys muta-
tion detected in the current Icelandic pedigree is a de
novo mutation. The fact that the mutation is absent
from 176,040 unrelated individuals but present in two
families with affected individuals confirms its role in
the pathogenesis of COPA syndrome. To understand
whether there is a mutational hotspot in the COPA
gene, more cases of the newly defined COPA syndrome
will have to emerge.
Additional files
Additional file 1: Figure S1. Lung biopsy section from the index case
(II-3) stained with hematoxylin and eosin. Mild interstitial lymphoid
infiltrate and multiple foci of lymphoid hyperplasia. (DOCX 579 kb)
Additional file 2: Table S1. Pulmonary function test results from the
three affected Icelanders with several years passing between the two
tests. (DOCX 13 kb)
Additional file 3: Figure S2. Lung biopsy section from the son of the
index case (III-1) stained with hematoxylin and eosin. Multiple lymphoid
follicles in the pulmonary interstitium and adjacent to a terminal
bronchiole (arrow). (DOCX 906 kb)
Additional file 4: Figure S3. Lung biopsy section from the daughter of
the index case (III-2) stained with hematoxylin and eosin. Multiple
lymphoid follicles in the interstitium and adjacent to airways (arrow).
(DOCX 856 kb)
Additional file 5: Table S2. Additional clinical features. Autoimmune
and rheumatological features as well as antibody titers for the three
patients. The medications and general measures taken to treat the
patients are listed. (DOCX 13 kb)
Additional file 6: Supplementary Information. Detailed description
of methods (sample preparation, whole-genome sequencing, alignment,
Table 1 The reported phenotypes for two affected family members of Family C in Watkin et al. compared to the phenotypes seen
in the affected Icelanders
Index case (II-3) Son (III-1) Daughter (III-2) Family C from Watkin et al. [2]
COPA mutation p.Glu241Lys p.Glu241Lys p.Glu241Lys p.Glu241Lys (2/2)
Sex Female Male Female Female (N = 2)
Age of onset Child 11 years old 18 months 2 and 4 years old
Respiratory/ Lung Lung restriction Lung obstruction – Lung restriction / obstruction (2/2)
Follicular bronchiolitis Follicular bronchiolitis Follicular bronchiolitis Interstitial lung disease (2/2)
Diffusion capacity defect Diffusion capacity defect Diffusion capacity defect Diffusion capacity defect (2/2)
Respiratory infections Respiratory infections Respiratory infections
Exercise intolerance Exercise intolerance Nail Clubbing
Pulmonary hypertension
Intra-alveolar hemorrhage Pulmonary hemorrhage (1/2)
Kidney – – – –
Joints Arthritis Arthritis, joint pain Arthritis Arthritis, joint pain (2/2)
Serologies ↑ ANA (mild) ↑ ANA ↑ ANA ↑ ANA (1/2)
↑ RF (mild) ↑ RF (very mild) ↑ RF ANCA neg. (2/2)
anti-CCP neg. ↑ anti-CCP (very mild) ↑ anti-CCP
ANCA neg. ANCA neg.
Immunoglobulins ↑ IgG (mild) ↑ IgG (mild), ↑ IgA (mild) ↓ IgG (total, IgG1 and IgG4), ↓ IgA ↑ IgG (1/2), ↑ IgA (1/2)
Therapy Lung transplantation Lung transplantation Steroids Steroids (2/2)
Oxygen therapy Oxygen therapy Immunosuppressants Immunosuppressants (2/2)
Steroids Steroids Bronchodilators
Immunosuppressants Immunosuppressants Immunoglobulins
Jensson et al. BMC Medical Genetics  (2017) 18:129 Page 4 of 5
variant calling and annotation) and the genetic analysis performed in this
study (Additional file 10: Table S5). (DOCX 23 kb)
Additional file 7: Figure S4. Variant filtering flowchart. We detected an
average of 4,942,809 coding and non-coding variants per affected member
of the family. Sixteen variants with MAF <0.1% in the Icelandic population
(MAF derived from 30,067 Icelandic genomes) were shared by the three
affected. Out of the 16 variants, one was private to the affected family
members. (DOCX 41 kb)
Additional file 8: Table S3. COPA mutation. Summary of the causative
mutation causing the lung disease in the Icelandic family. (DOCX 19 kb)
Additional file 9: Table S4. Sequencing data metrics for the COPA
mutation. The call ratios of the COPA mutation for the index case,
affected son and daughter, and unaffected husband, mother, and father
from the WGS data. Additionally, the Sanger sequencing genotypes for
the three siblings of the index case are listed. (DOCX 13 kb)
Additional file 10: Table S5. Coding variants with MAF < 0.1% in
Iceland shared between all three affected family members. (DOCX 14 kb)
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